Last reviewed · How we verify
NCT07471646
Effects of Ramadan Fasting With Exercise on Cardiometabolic Health
NA trial testing Moderate-Intensity Aerobic Exercise in Ramadan Fasting in 30 participants. Not yet recruiting.
1 May 2026
Quick facts
| Lead sponsor | University of Michigan |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 25 March 2026 |
| Primary completion | 1 May 2026 |
| Estimated completion | 1 May 2026 |
Drugs / interventions tested
- Moderate-Intensity Aerobic Exercise
Conditions studied
- Ramadan Fasting — all drugs for Ramadan Fasting →
- Obesity & Overweight — all drugs for Obesity & Overweight →
- Aerobic Exercise — all drugs for Aerobic Exercise →
- Weight Loss — all drugs for Weight Loss →
Sponsor
University of Michigan
Who can join
Adults 20 to 60, any sex, with Ramadan Fasting or Obesity & Overweight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this interventional study is to examine the effects of Ramadan diurnal fasting alone and in combination with moderate-intensity aerobic exercise on cardiometabolic health in adults with overweight and obesity. The main questions it aims to answer are: 1. Does Ramadan diurnal fasting lead to changes in body composition and cardiometabolic health outcomes? 2. Does adding moderate-intensity aerobic exercise during Ramadan fasting result in greater improvements in cardiometabolic health compared with fasting alone? Participants will be randomly assigned to one of two groups: Ramadan diurnal fasting only or Ramadan diurnal fasting combined with a supervised moderate-intensity aerobic exercise program. Cardiometabolic, metabolic, and behavioral outcomes will be assessed before Ramadan and during the last week of Ramadan.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07471646
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Moderate-Intensity Aerobic Exercise
Trials testing the same drug.
- NCT03975491 — The Exercise And Colorectal Cancer Treatment Trial · NA · active not recruiting
Other recruiting trials for Ramadan Fasting
Currently open trials in the same condition.
- NCT06826547 — Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations · EARLY_PHASE1 · active not recruiting
Other University of Michigan trials
Trials by the same sponsor.
- NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
- NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
- NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
- NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting
- NCT07326748 — Lakota Family Acceptance Project · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07471646 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Michigan
- Last refreshed: 13 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07471646.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing